Effects of primary hypertension treatment in the oncological outcomes of hepatocellular carcinoma

Department of Surgery, Department of Pathology, Department of Anesthesiology, Virgen de la Arrixaca University Hospital, Biomedical Research Institute of Murcia-Virgen de la Arrixaca (IMIB-Arrixaca), Murcia, Spain Correspondence to: Victor Lopez-Lopez. General and Digestive Surgery Department, “Virgen de la Arrixaca” University Hospital, Ctra. MadridCartagena, s/n, 30120 El Palmar, Murcia, Spain. Email: victorrelopez@gmail.com. Provenance and Peer Review: This article was commissioned by the editorial office, Annals of Translational Medicine. The article did not undergo external peer review. Comment on: Feng LH, Sun HC, Zhu XD, et al. Renin-angiotensin inhibitors were associated with improving outcomes of hepatocellular carcinoma with primary hypertension after hepatectomy. Ann Transl Med 2019;7:739.